Clinical Trials
12 trialsNCT03767257 2025-10-21
A Study of Colesevelam for Lenalidomide-Associated Diarrhea
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT03499808 2025-09-09
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
Phase 2 Completed
NCT02944617 2024-02-23
Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor
City of Hope Medical Center
Phase NA Completed
NCT00774930 2022-10-14
ELECT
Ipsen
Phase 3 Completed
NCT01371656 2020-12-07
Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoing Stem Cell Transplantation
Children's Oncology Group
Phase 3 Completed
NCT00748215 2020-12-02
Calcium Aluminosilicate Anti-Diarrheal in Treating and Preventing Diarrhea in Patients With Metastatic Colorectal Cancer Receiving Irinotecan
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01198145 2020-05-12
Sulfasalazine in Preventing Acute Diarrhea in Patients With Cancer Who Are Undergoing Pelvic Radiation Therapy
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT02294786 2019-07-15
Study of Prophylactic Octreotide to Prevent or Reduce the Frequency and Severity of Diarrhoea in Subjects Receiving Lapatinib With Capecitabine for the Treatment of Metastatic Breast Cancer
Novartis
Phase 2 Terminated
NCT00258180 2019-04-16
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
Johns Hopkins University
Phase 2 Completed
NCT02018653 2018-07-26
CASAD for Severe Diarrhea in the Emergency Department
M.D. Anderson Cancer Center
Phase NA Terminated
NCT00582426 2015-05-04
LARCID
Novartis
Phase 3 Completed
NCT01886287 2015-01-12
P:II Above-Label Octreotide-LAR With Insufficiently Controlled Carcinoid Syndrome
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Terminated